trihexyphenidyl has been researched along with Atrophy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of symptomatic hemidystonia of delayed onset." | 1.28 | Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus. ( Aarli, JA; Julsrud, OJ; Midgard, R; Odegaard, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Midgard, R | 1 |
| Aarli, JA | 1 |
| Julsrud, OJ | 1 |
| Odegaard, H | 1 |
1 other study available for trihexyphenidyl and Atrophy
| Article | Year |
|---|---|
Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus.
Topics: Adult; Atrophy; Basal Ganglia; Caudate Nucleus; Cerebral Infarction; Dystonia; Humans; Magnetic Reso | 1989 |